NCT01161147View on ClinicalTrials.gov

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

Meloxicam

Meloxicam Tablets 15 mg

Trial Locations (1)

L4W 1N2

Allied Research International Inc., Mississauga

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY